Mesothelioma is typically hard to treat and medical procedures used to slow down the progression of mesothelioma are difficult because of the complexity of the procedure and the toll it takes on the patient.
Dr. Rodney J. Landreneau, Director of the Ochsner Cancer Institute, has brought a groundbreaking surgical treatment to Louisiana for mesothelioma patients: hyperthermic intraperitoneal chemoperfusion (HIPEC).
HIPEC involves removing all visible tumors from a patient’s chest cavity, usually saving the lungs, and then instilling a heated chemotherapy solution throughout the chest cavity to treat microscopic tumor cells that may remain. This kills a much higher number of cancer cells than traditional tumor removal.
“The survival rate [for those with mesothelioma] has almost doubled among selected patients with favorable cell types that are cleared from the chest,” Dr. Landreneau says. “This therapy provides hope for the many patients with this potentially devastating disease."
Find out if you’re at risk for malignant mesothelioma.